• SENSEX 76,738.17
    585.31 (+0.77%)
  • BANKNIFTY 57,380.60
    208.60 (+0.36%)
  • Gland Pharma
    2,826.60 1,575.00(%)
  • Tata Technolog.
    830.10 890.15(%)
  • IFCI
    103.95 101.60(%)
  • HFCL
    231.40 257.00(%)
  • Lumino Inds
    122.00 119.00(%)
  • Jindal Worldwide
    57.06 47.55(%)
  • Netweb Technol.
    5,424.00 5,810.00(%)
  • Angel One
    308.20 360.20(%)
  • HBL Engineering
    723.85 1,121.95(%)
  • Multi Comm. Exc.
    3,257.00 3,479.80(%)
  • Adani Total Gas
    620.85 859.70(%)
  • Lenskart Solut.
    694.75 680.95(%)
  • Oberoi Realty
    1,932.25 1,985.00(%)
  • RBL Bank
    413.50 410.45(%)
  • Tejas Networks
    613.50 644.75(%)
  • Polycab India
    8,308.55 6,660.50(%)
  • Antelopus Selan
    986.05 357.00(%)
  • Nuvoco Vistas
    353.50 477.35(%)
  • One 97
    1,691.50 1,732.00(%)
  • Reliance Industries
    1,332.30 1,611.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Source Natural Foods & Herbal Supplements Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 13792.0
  • ISIN : INE679C01027
107.05 0 (-0.23%)
  • As on 04 Sep 2026 (EOD)

  • Today’s Low

    106.00

  • Today’s High

    110.00

  • Open

    106.00

  • Perv Close

    107.30

  • 52W Low

    96.55

  • 52W High

    170.00

Key Indicators

  • P/E(TTM)

    19.64

  • Mar.Cap (₹Cr.)

    68.91

  • Div & Yield %

    0.00

  • Book Value(₹)

    40.01

  • Debt-Equity Ratio

    -0.23

  • AGM Date

    03-Sep-2026

  • EPS

    5.45

  • P/E Ratio

    19.64

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    68.91

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    6.44

  • BV (₹)

    40.00

  • Sales( ₹ in Cr.)

    70.38

  • NP (in Cr.)

    3.40

  • NP Var(%)

    17.0

  • Div%

    0.0

  • CPS (₹)

    5.90

  • EPS (₹)

    5.30

  • Traded Value (₹ in Lakhs)

    68.91

  • 52 Week High

    170.00

  • 52 Week Low

    96.55

  • Price BSE

    107.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    68.91

  • P/C Ratio

    18.20

  • P/E Ratio

    20.30

  • Price Vs.BV

    5.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 44.92 27.30 19.79 21.53 24.88 15.11
Excise Duty 0.00 0.00 0.00 0.00 0.00 1.52
Net Sales 44.92 27.30 19.79 21.53 24.88 13.59
Other Income 0.08 0.01 0.01 0.49 0.34 0.02
Stock Adjustments 1.09 1.39 0.40 0.62 -0.07 -0.33
Total Income 46.09 28.70 20.20 22.64 25.15 13.28
EXPENDITURE :            
Raw Materials 34.56 18.16 10.25 10.05 9.84 4.53
Power and Fuel Cost 0.28 0.30 0.28 0.32 0.33 0.24
Employee Cost 3.27 2.88 3.14 3.86 2.54 2.29
Other Manufacturing Expenses 1.62 1.60 1.35 1.98 2.12 1.72
Selling and Administration Expenses 1.14 1.27 1.56 1.86 4.86 1.97
Miscellaneous Expenses 0.00 0.05 0.00 0.22 0.94 0.13
Employee Benefit Expenses 3.27 2.88 3.14 3.86 2.54 2.29
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 40.87 24.26 16.57 18.30 20.64 10.88
Operating Profit 5.22 4.43 3.62 4.34 4.50 2.41
Interest 0.62 0.21 0.27 0.24 0.10 0.23
Gross Profit 4.60 4.22 3.35 4.10 4.40 2.18
Depreciation 1.02 1.04 0.62 0.42 0.37 0.34
Profit Before Tax 3.58 3.18 2.73 3.68 4.03 1.84
Current Tax 0.68 1.12 0.61 0.91 1.32 0.43
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.32 0.01 0.34 -0.66 -0.22
Reported Net Profit 2.90 1.74 2.12 2.43 3.37 1.64
Extraordinary Items 0.00 -0.03 0.00 0.00 -0.01 0.00
Adjusted Net Profit 2.90 1.77 2.12 2.43 3.38 1.64
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 11.88 10.14 8.02 5.59 2.21 1.22
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.64
P & L Balance carried down 14.78 11.88 10.14 8.02 5.59 2.21
Dividend 0.00 0.00 0.00 0.00 0.00 0.64
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 4.51 2.70 3.30 3.78 5.24 2.55
Earnings Per Share(Adj)-Unit Curr 4.51 2.70 3.30 3.78 5.24 2.55
Book Value 34.73 30.22 27.52 24.23 20.45 15.21
Book Value(Adj)-Unit Curr 34.73 30.22 27.52 24.23 20.45 15.21

Shareholding Pattern

  • Promoter Group

    74.37%

  • Public Share Holding

    25.63%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,786,891 74.37 4,786,891 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,786,891 74.37 4,786,891 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 149,153 2.32 147,653 39
Clearing Members 0 0.00 0 0
Directors of their Relatives 11,801 0.18 11,801 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 135,903 2.11 135,753 36
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 61,448 0.95 61,448 70
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 561,027 8.72 561,027 12
Individuals holding nominal share capital up to Rs. 1 lakh 701,184 10.89 675,635 3,464
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 158 0.00 0 1
Others 27,365 0.43 27,365 1
Sub Total 1,650,040 25.63 1,622,683 3,627
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,436,931 100.00 6,409,574 3,628

Company Background

Source Natural Foods & Herbal Supplements LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Source Natural Foods & Herbal Supplements Ltd
  • BSE Code : 13792.0
  • ISIN : INE679C01027

  • Incorporation Year

    1995

  • Registered Office

    201 2nd Floor Sumeru Towers
    54/46 39 Jayanagar 4th Block, Bangaluru,
    Karnataka-560041

  • Telephone

    91-80-26087733

  • FAX

    91-80-22449505

  • Chairman

    NARAYANAN NARASIMHAN

  • Managing Director

    Arvind Varchaswi N

  • Company Secretary

    Yash Jain

  • Auditor

    Srinaga & Giridharan

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Source Natural Foods & Herbal Supplements Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Source Natural 107.05 45.00 44.92 19.64 16.33
Abbott India 25,878.50 7,217.19 6,929.05 34.06 43.78
Astrazeneca Phar 6,946.95 2,304.07 2,275.58 102.39 27.86
Glaxosmi. Pharma 2,935.35 3,932.76 3,790.20 46.89 58.17
Novartis India 1,614.95 398.23 356.27 40.78 16.64
Cipla 1,389.00 20,102.60 18,979.95 36.50 13.88
Bliss GVS Pharma 636.90 773.53 729.81 59.14 12.51
Amrutanjan Healt 507.20 520.13 502.55 27.17 24.16
Fermenta Biotec. 502.80 474.15 450.25 23.47 18.77
Guj. Themis Bio. 425.00 152.47 150.80 113.64 27.21
Ambalal Sarabhai 43.88 19.52 3.94 81.26 6.77